A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures
Clinical trial NCT04244175 · COMPLETED
Trial details
- NCT number
- NCT04244175
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-27
- Primary completion
- 2024-05-21
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.